
Tell us about the pharmaceutical product, destination country and available documents. Using this information, we explain whether supply discussions can continue and which confirmations are still needed.
After the initial review, we explain whether there is enough product information to discuss further specialist checks.
Goods, market, recipient and purpose are clear. We clarify which information and participants are still missing.
We request missing composition, form, manufacturer, batch, expiry or market details before discussing transport and payment.
If information is unconfirmed or contradictory, we do not promise approval, a route, price or outcome until verifiable information is available.
Product category, documents, responsible parties and temperature requirements determine what must be confirmed before purchasing. There is no single route for all pharmaceutical products.
Medicines, dietary supplements, pharmaceutical substances and controlled categories need different information and do not follow a single scenario.
We clarify the documents provided, market and parties involved. Authorised parties confirm registration, permits and classification.
Shelf life, batch, packaging and temperature determine which conditions need confirmation before purchasing.
Only after specialist checks can contractor, storage and specific route availability be discussed.
The customer specifies the product, market and recipient role; the supplier provides available batch information. OZTA organises the preliminary review, while authorised parties confirm permit, storage and transport applicability for the specific scenario.
Do not send prescriptions, diagnoses, patient details or other personal medical information. Product and shipment information is sufficient for the initial enquiry.
Before payment, we show a specific offer for the agreed scope. There is no fixed preliminary-check rate or universal supply package here: scope depends on goods, country and participants.
These answers concern preliminary pharmaceutical-product review and do not replace a doctor, regulator or authorised importer. Final terms depend on category, country, batch and documents.
Provide the active ingredient or trade name, form and dosage, manufacturer, destination market, prescription or controlled status if known, batch, expiry, storage conditions and quantity.
They differ in purpose, registration status, documents, licences and storage conditions. Before calculation, we identify the category and do not transfer rules from one category to another.
A competent authority confirms the specific scenario's status and possible exceptions for the stated country and recipient. We collect purpose, recipient and documents for this review; universal approval is not promised.
We record temperature-range and packaging requirements and send them to the selected parties for checking. Monitoring and actions for deviations are possible only within a scope confirmed in writing; without confirmation, we pause purchasing.
The requirement depends on category, importer role, country and scenario. We check which licences and permits may apply, but do not substitute them for a regulator's decision or promise they will be obtained.
We pause the review if composition, documents, origin, batch or expiry, controlled status, storage conditions, export restrictions or recipient details are unconfirmed.
Tell us about the product, destination country and available product documents. We explain whether the review can continue. Do not send prescriptions, diagnoses or patient details.
Tell us about the task